MABS819 Sigma-AldrichAnti-GAPDH (CT) Antibody, clone RM114
This Anti-GAPDH (CT) Antibody, clone RM114 is validated for use in Western Blotting, Immunocytochemistry for the detection of GAPDH (CT).
More>> This Anti-GAPDH (CT) Antibody, clone RM114 is validated for use in Western Blotting, Immunocytochemistry for the detection of GAPDH (CT). Less<<Recommended Products
Overview
Replacement Information |
---|
Key Specifications Table
Species Reactivity | Key Applications | Host | Format | Antibody Type |
---|---|---|---|---|
H | WB, ICC | Rb | Purified | Monoclonal Antibody |
References |
---|
Product Information | |
---|---|
Format | Purified |
Presentation | Rabbit monoclonal in PBS with 1% BSA and 0.09% sodium azide. |
Quality Level | MQ300 |
Physicochemical Information |
---|
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS |
---|
Safety Information |
---|
Packaging Information | |
---|---|
Material Size | 100 µL |
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
Catalog Number | GTIN |
MABS819 | 04055977181531 |
Documentation
Anti-GAPDH (CT) Antibody, clone RM114 SDS
Title |
---|
Anti-GAPDH (CT) Antibody, clone RM114 Certificates of Analysis
Title | Lot Number |
---|---|
Anti-GAPDH (CT), clone RM114 -VP1811300 | VP1811300 |
Anti-GAPDH (CT), clone RM114 - VP1912273 | VP1912273 |
Anti-GAPDH (CT), clone RM114 - VP2108264 | VP2108264 |
Anti-GAPDH (CT), clone RM114 - VP2309201 | VP2309201 |
Anti-GAPDH (CT), clone RM114 - VP2407247 | VP2407247 |
Anti-GAPDH (CT), clone RM114 -QVP1503207 | QVP1503207 |
Anti-GAPDH (CT), clone RM114 Monoclonal Antibody | VP1706195 |
Anti-GAPDH (CT), clone RM114 Monoclonal Antibody | VP1807279 |
Brochure
Title |
---|
New Products Flyer- Vol 4 Signaling Feature- NEW! Phosphohistidine Antibody |
Technical Info
Title |
---|
Characterization of Estrogen Receptor α Phosphorylation Sites in Breast Cancer Tissue Using the SNAP i.d® 2.0 System |
White Paper: Further considerations of antibody validation and usage. |
Posters
Title |
---|
Post-Translational Modifications |